PortfoliosLab logoPortfoliosLab logo
BIIB vs. VHT
Performance
Return for Risk
Dividends
Drawdowns
Volatility

Performance

BIIB vs. VHT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Biogen Inc. (BIIB) and Vanguard Health Care ETF (VHT). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

BIIB vs. VHT - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
BIIB
Biogen Inc.
4.17%15.09%-40.91%-6.55%15.42%-2.02%-17.48%-1.39%-5.54%12.34%
VHT
Vanguard Health Care ETF
-5.04%15.46%2.66%2.52%-5.60%20.57%18.29%21.87%5.58%23.26%

Returns By Period

In the year-to-date period, BIIB achieves a 4.17% return, which is significantly higher than VHT's -5.04% return. Over the past 10 years, BIIB has underperformed VHT with an annualized return of -3.45%, while VHT has yielded a comparatively higher 9.72% annualized return.


BIIB

1D
-2.26%
1M
-4.43%
YTD
4.17%
6M
30.88%
1Y
33.97%
3Y*
-12.96%
5Y*
-8.04%
10Y*
-3.45%

VHT

1D
2.24%
1M
-7.50%
YTD
-5.04%
6M
5.91%
1Y
4.70%
3Y*
6.16%
5Y*
5.09%
10Y*
9.72%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BIIB vs. VHT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BIIB
BIIB Risk / Return Rank: 7373
Overall Rank
BIIB Sharpe Ratio Rank: 7575
Sharpe Ratio Rank
BIIB Sortino Ratio Rank: 7272
Sortino Ratio Rank
BIIB Omega Ratio Rank: 6666
Omega Ratio Rank
BIIB Calmar Ratio Rank: 7777
Calmar Ratio Rank
BIIB Martin Ratio Rank: 7777
Martin Ratio Rank

VHT
VHT Risk / Return Rank: 2121
Overall Rank
VHT Sharpe Ratio Rank: 2020
Sharpe Ratio Rank
VHT Sortino Ratio Rank: 2020
Sortino Ratio Rank
VHT Omega Ratio Rank: 1919
Omega Ratio Rank
VHT Calmar Ratio Rank: 2525
Calmar Ratio Rank
VHT Martin Ratio Rank: 2121
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BIIB vs. VHT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Biogen Inc. (BIIB) and Vanguard Health Care ETF (VHT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


BIIBVHTDifference

Sharpe ratio

Return per unit of total volatility

0.99

0.27

+0.72

Sortino ratio

Return per unit of downside risk

1.63

0.49

+1.14

Omega ratio

Gain probability vs. loss probability

1.19

1.06

+0.13

Calmar ratio

Return relative to maximum drawdown

1.90

0.51

+1.38

Martin ratio

Return relative to average drawdown

4.80

1.09

+3.70

BIIB vs. VHT - Sharpe Ratio Comparison

The current BIIB Sharpe Ratio is 0.99, which is higher than the VHT Sharpe Ratio of 0.27. The chart below compares the historical Sharpe Ratios of BIIB and VHT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


BIIBVHTDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.99

0.27

+0.72

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.21

0.34

-0.56

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.08

0.58

-0.66

Sharpe Ratio (All Time)

Calculated using the full available price history

0.22

0.56

-0.34

Correlation

The correlation between BIIB and VHT is 0.60, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Dividends

BIIB vs. VHT - Dividend Comparison

BIIB has not paid dividends to shareholders, while VHT's dividend yield for the trailing twelve months is around 1.73%.


TTM20252024202320222021202020192018201720162015
BIIB
Biogen Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
VHT
Vanguard Health Care ETF
1.73%1.61%1.53%1.36%1.33%1.14%1.21%1.89%1.38%1.31%1.45%1.22%

Drawdowns

BIIB vs. VHT - Drawdown Comparison

The maximum BIIB drawdown since its inception was -89.98%, which is greater than VHT's maximum drawdown of -39.12%. Use the drawdown chart below to compare losses from any high point for BIIB and VHT.


Loading graphics...

Drawdown Indicators


BIIBVHTDifference

Max Drawdown

Largest peak-to-trough decline

-89.98%

-39.12%

-50.86%

Max Drawdown (1Y)

Largest decline over 1 year

-14.13%

-10.40%

-3.73%

Max Drawdown (5Y)

Largest decline over 5 years

-72.66%

-17.71%

-54.95%

Max Drawdown (10Y)

Largest decline over 10 years

-72.66%

-28.85%

-43.81%

Current Drawdown

Current decline from peak

-61.48%

-8.05%

-53.43%

Average Drawdown

Average peak-to-trough decline

-36.48%

-5.98%

-30.50%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.78%

4.96%

+1.82%

Volatility

BIIB vs. VHT - Volatility Comparison

Biogen Inc. (BIIB) has a higher volatility of 8.91% compared to Vanguard Health Care ETF (VHT) at 5.10%. This indicates that BIIB's price experiences larger fluctuations and is considered to be riskier than VHT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


BIIBVHTDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.91%

5.10%

+3.81%

Volatility (6M)

Calculated over the trailing 6-month period

24.16%

10.28%

+13.88%

Volatility (1Y)

Calculated over the trailing 1-year period

34.48%

17.61%

+16.87%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

38.11%

14.85%

+23.26%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

41.40%

16.94%

+24.46%